propidium has been researched along with 3,4-dihydroxyphenylglycol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baskys, A; Bayazitov, I; Blaabjerg, M; Fang, L; Poulsen, FR; Zimmer, J | 1 |
| Gerace, E; Landucci, E; Moroni, F; Pellegrini-Giampietro, DE; Scartabelli, T | 1 |
2 other study(ies) available for propidium and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzoates; Cell Count; Cell Death; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Estrenes; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Glycine; Hippocampus; Immunohistochemistry; In Vitro Techniques; Methoxyhydroxyphenylglycol; Models, Biological; N-Methylaspartate; Nerve Tissue Proteins; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Propidium; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate | 2005 |
Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy?
Topics: Analysis of Variance; Animals; Animals, Newborn; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Methoxyhydroxyphenylglycol; Oncogene Protein v-akt; Organ Culture Techniques; Phosphatidylinositol 3-Kinases; Propidium; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Signal Transduction; Time Factors | 2008 |